Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pettit

Showing results (421-430 of 659) with videos related to

Pageof 66
Sort By:
Health Services Research|July 25, 2017
Impact of Cost-Sharing Increases on Continuity of Specialty Drug Use: A Quasi-Experimental StudyPengxiang Li, Tianyan Hu, Xinyan Yu, et al.
The American Journal of Managed Care|June 9, 2016
High cost sharing and specialty drug initiation under Medicare Part D: a case study in patients with newly diagnosed chronic myeloid leukemiaJalpa A Doshi, Pengxiang Li, Hairong Huo, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|July 8, 1998
High-performance liquid chromatographic assay for the novel antitumor drug, bryostatin-1, incorporating a serum extraction techniqueP Khan, A T McGown, M J Dawson, et al.
Journal of Natural Products|December 28, 2002
Lyngbyastatin 1 and Ibu-epilyngbyastatin 1: synthesis, stereochemistry, and NMR line broadeningRuoli Bai, Robert B Bates, Ernest Hamel, et al.
Leukemia Research|September 1, 1995
Bryostatin 1 induces apoptosis and augments inhibitory effects of vincristine in human diffuse large cell lymphomaR M Mohammad, H Diwakaran, A Maki, et al.
Anti-Cancer Drug Design|June 7, 2002
Antineoplastic agents 460. Synthesis of combretastatin A-2 prodrugsG R Pettit, B R Moser, M R Boyd, et al.
Journal of Natural Products|August 23, 2003
Isolation and structure of ruprechstyril from Ruprechtia tangaranaGeorge R Pettit, Yanhui Meng, Delbert L Herald, et al.
Experimental Hematology|February 12, 2020
Imaging flow cytometry reveals that granulocyte colony-stimulating factor treatment causes loss of erythroblastic islands in the mouse bone marrowJoshua Tay, Kavita Bisht, Crystal McGirr, et al.
Biochemical Pharmacology|April 6, 1993
Differential effects of active isomers, segments, and analogs of dolastatin 10 on ligand interactions with tubulin. Correlation with cytotoxicityR Bai, M C Roach, S K Jayaram, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|March 11, 2015
Unilateral loss of spontaneous venous pulsations in an astronautThomas H Mader, C Robert Gibson, Andrew G Lee, et al.
Pageof 66

Showing results (421-430 of 659) with videos related to

Sort By:
Pageof 66
Health Services Research|July 25, 2017
Impact of Cost-Sharing Increases on Continuity of Specialty Drug Use: A Quasi-Experimental StudyPengxiang Li, Tianyan Hu, Xinyan Yu, et al.
The American Journal of Managed Care|June 9, 2016
High cost sharing and specialty drug initiation under Medicare Part D: a case study in patients with newly diagnosed chronic myeloid leukemiaJalpa A Doshi, Pengxiang Li, Hairong Huo, et al.
Journal of Chromatography. B, Biomedical Sciences and Applications|July 8, 1998
High-performance liquid chromatographic assay for the novel antitumor drug, bryostatin-1, incorporating a serum extraction techniqueP Khan, A T McGown, M J Dawson, et al.
Journal of Natural Products|December 28, 2002
Lyngbyastatin 1 and Ibu-epilyngbyastatin 1: synthesis, stereochemistry, and NMR line broadeningRuoli Bai, Robert B Bates, Ernest Hamel, et al.
Leukemia Research|September 1, 1995
Bryostatin 1 induces apoptosis and augments inhibitory effects of vincristine in human diffuse large cell lymphomaR M Mohammad, H Diwakaran, A Maki, et al.
Anti-Cancer Drug Design|June 7, 2002
Antineoplastic agents 460. Synthesis of combretastatin A-2 prodrugsG R Pettit, B R Moser, M R Boyd, et al.
Journal of Natural Products|August 23, 2003
Isolation and structure of ruprechstyril from Ruprechtia tangaranaGeorge R Pettit, Yanhui Meng, Delbert L Herald, et al.
Experimental Hematology|February 12, 2020
Imaging flow cytometry reveals that granulocyte colony-stimulating factor treatment causes loss of erythroblastic islands in the mouse bone marrowJoshua Tay, Kavita Bisht, Crystal McGirr, et al.
Biochemical Pharmacology|April 6, 1993
Differential effects of active isomers, segments, and analogs of dolastatin 10 on ligand interactions with tubulin. Correlation with cytotoxicityR Bai, M C Roach, S K Jayaram, et al.
Journal of Neuro-Ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society|March 11, 2015
Unilateral loss of spontaneous venous pulsations in an astronautThomas H Mader, C Robert Gibson, Andrew G Lee, et al.
Pageof 66